Advertisement
According to the company announcement, Dr. Zhu got his college educationin chemistry in Nanjing University in China. After research work in China fora few years, he left the country for graduate study in the United States andobtained his PhD degree from Colorado State University in 1995. Later hejoined the chemistry research and discovery team at Amgen, a giant inpharmaceutical industry, garnering 10 years of experience in the fields of newdrug development and management. Two months ago, Dr. Zhu decided to leave hiscareer in US and move to Shanghai with his family to join Sundia.
Advertisement
Dr. Gao received his PhD degree from the Institute of Organic Chemistry inShanghai in 1995, and in the same year he went to Canada to pursue his postdoctorate training. Upon completing his program, he joined Canada's largestCRO company, MDS Pharma Services Inc, and gathered bountiful workingexperience in pharmaceutical CRO services for 5 years. In 2003, Dr. Gaoaccepted a professorship offer from Jilin University in Changchun, China. Hejoined Sundia in 2004, right after the formation of the company. For the past3 years, Dr. Gao progressed step by step from the company's chemistry researchdirector, to executive director, and now to vice president.
According to Sundia's CEO Dr. Xiaochuan Wang, the company's CRO servicebusiness has been growing at an amazing rate. Last year alone, their revenueincreased more than 150%. To match this rapid expansion in both businessscope and size, the company is constantly adding outstanding personnel to itsexecutive management team. In early 2007, the company headhunted Mr. BeijiaYu from a Fortune 500 multinational company in US to take the company's CFOposition. Mr. Yu had an excellent track record in corporate financialmanagement from his long term career in United States. "I am very happy tosee so many high level talents to join our effort in Sundia. That willgreatly help Sundia to become a leading player in the global CRO market".Said Dr. Wang.
About the company:
Sundia MediTech was founded in Shanghai in 2004 by a group of veterans ofthe US pharmaceutical industry to provide drug discovery and development CROservices. Seeing the rapidly developing global CRO industry, the foundersleft their positions in the US and came to China to start their own company.Over the past 3 years, Sundia has thrived and built a strong reputation in itsfield. Following a 2007 merger with neighbor United PharmaTech, Sundia looksforward to continuing its phenomenal growth rate.
SOURCE Sundia MediTech (Shanghai) Company
